Get In Touch
29924 Jefferson Avenue
Saint Clair Shores, MI, 48082
Ph: +1-855-542-5672 | +1 (855 KICK-MSA)

LEARN ABOUT THIS STUDY – WITH STUDY CENTERS IN USA AND OUTSIDE OF USA HERE: https://cypress-study.com/

Theravance Biopharma is researching the investigational drug (ampreloxetine) because they believe it may reduce nOH symptoms that interfere with daily activity in MSA patients based on prior clinical trial results. They are running the Phase 3 CYPRESS trial to confirm whether the investigational drug is effective and safe in treating nOH symptoms in MSA patients and to learn about any unwanted side effects.

Neurogenic Orthostatic Hypotension involves issues with regulating blood pressure. Many people diagnosed with MSA may exhibit nOH symptoms.

Philip Fortier
Philip Fortier
https://defeatmsa.org

This website stores cookies on your computer. Cookie Policy

Translate »